MetaCap

Kalaris Therapeutics Statistics

NASDAQ: KLRSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.28-0.07 (-5.19%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Kalaris Therapeutics by the numbers

Kalaris Therapeutics has a market capitalization of $30.5 million based on 23.80M shares outstanding. With trailing EPS of $-1.84, Kalaris Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 45.0% below its 50-day average and 73.6% below its 200-day average.

Average daily trading volume is 77.37K shares, or about $99,035 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

KLRS valuation vs. peer median

KLRS compared with the median of 8 peer companies
MetricKLRSPeer medianDifference
Market cap$30.47M$26.01M+17%
Avg. volume77.37K124.11K-38%

Peer median across 8 companies: CRBU, EXOZ, LONA, INMB, TIL, PTHS, SAEN, MGX.

Valuation

Price and trading

Previous close
1.35
Open
1.31
Day range
1.25 – 1.37
52-week range
1.25 – 11.88
52-week change
-81.74%
Beta
—
Volume
37.99K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
30.47M
Forward Pe
-0.75
Eps
-1.84
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
11.88
Week52 Low
1.25
Avg Volume
77,371.00
Shares Outstanding
23.80M
Ma50
2.33
Ma200
4.84
Earnings Date
Aug 7, 2025
Pct From52w High
-89.23%
Pct From52w Low
2.40%

Related